What does a markedly elevated IgA anti‑tissue transglutaminase (tTG) level of 422 U/mL indicate, and what are the appropriate next steps for diagnosis and management?

Celiac IgA 422: Highly Suggestive of Active Celiac Disease

A tissue transglutaminase IgA (tTG-IgA) level of 422 U/mL is markedly elevated and highly indicative of active celiac disease, but you must obtain confirmatory testing with endomysial antibody (EMA) on a second blood sample and proceed to upper endoscopy with duodenal biopsies for definitive diagnosis in adults. 1

What This Level Means

Your tTG-IgA of 422 U/mL represents a dramatically elevated value that far exceeds the diagnostic threshold. Assuming a typical upper limit of normal (ULN) around 15-20 U/mL, this level is approximately 21-28 times the ULN, which is well above the critical 10× ULN threshold that guidelines emphasize.

At levels >10× ULN combined with positive EMA, the positive predictive value for celiac disease approaches virtually 100% 1. This means the diagnosis is almost certain when both tests are positive.

Immediate Next Steps

1. Obtain Confirmatory Serology

• Draw a second blood sample for endomysial antibody (EMA) testing 1
• Recent evidence suggests that a repeat tTG-IgA on the second sample may be equally reliable as EMA, with all patients having high-positive initial tTG-IgA maintaining both high tTG-IgA and positive EMA on confirmatory testing 2, 3
• However, the established guideline recommendation remains EMA confirmation 1

2. Proceed to Endoscopy with Duodenal Biopsies

In adults, you should still perform esophagogastroduodenoscopy (EGD) with duodenal biopsies even with such strongly positive serology 1. The biopsy serves purposes of:

• Differential diagnosis (ruling out other causes of villous atrophy)
• Establishing baseline histologic severity
• Documenting the diagnosis definitively

The guideline explicitly states that at these high tTG-IgA levels, biopsies "may then be performed for purposes of differential diagnosis" rather than being omitted 1.

3. Ensure Patient Remains on Gluten-Containing Diet

• Do not start a gluten-free diet before completing diagnostic testing 1
• Gluten avoidance reduces sensitivity of both serology and biopsy
• Patient should continue normal gluten intake (equivalent to 3 slices of wheat bread daily) until all testing is complete 1

Important Caveats and Pitfalls

Check Total IgA Level

While less likely with such a high tTG-IgA, you should verify the patient does not have IgA deficiency 1. IgA deficiency occurs in ~2-3% of celiac patients and would invalidate IgA-based testing. If IgA is low/absent, use IgG-based tests (IgG-DGP, tTG-IgG).

Consider Associated Conditions

Extremely high tTG-IgA levels (>310 U/mL, which applies here) are associated with:

• Nearly 5-fold increased odds of celiac hepatitis 4
• Check liver enzymes (AST, ALT, alkaline phosphatase) at baseline
• These typically normalize on gluten-free diet

False Positives Are Rare But Exist

Even at ≥10× ULN, the positive predictive value is not 100%:

• Recent pediatric data shows PPV of 94.9% at ≥10× ULN 5
• Adult data suggests PPV of 98.6% at 11.4× ULN 6
• Type 1 diabetes mellitus is associated with higher false-positive rates (PPV drops to 89% in diabetics) 5, 3
• All three false-positive cases in one study with tTG ≥10× ULN also had false-positive EMA, and two had type 1 diabetes 3

Biopsy Findings to Expect

With a tTG-IgA of 422 U/mL, you should expect:

• Marsh 3 lesions (villous atrophy) in the vast majority of cases 7, 8
• All patients with tTG-IgA >50 U/mL in screening studies had confirmed celiac disease 7
• Biopsies should be evaluated with Marsh classification, intraepithelial lymphocyte counting, and morphometry 1

Diagnostic Algorithm Summary

1. Confirm patient is on gluten-containing diet → If not, delay testing until after gluten challenge
2. Order second blood sample → EMA (or repeat tTG-IgA per emerging evidence)
3. Check total IgA level → If deficient, switch to IgG-based testing
4. Check baseline liver enzymes → Given very high tTG-IgA level
5. Schedule upper endoscopy → Obtain ≥4 duodenal biopsies from second/third portion of duodenum
6. If EMA positive + biopsy shows villous atrophy → Definitive celiac disease diagnosis
7. Initiate gluten-free diet → Only after diagnostic confirmation

Special Consideration: No-Biopsy Approach

The European pediatric guidelines allow diagnosis without biopsy in children with tTG-IgA ≥10× ULN plus positive EMA 7, 8. However, this has not been adopted in North America for adults 1, 5, and given the diagnostic accuracy concerns (especially with comorbid type 1 diabetes), biopsy confirmation remains the gold standard in routine clinical practice 6.

The strength of your evidence (tTG-IgA of 422) makes celiac disease highly likely, but completing the diagnostic algorithm ensures you haven't missed the small percentage of false positives and establishes a definitive baseline for future management.